CANF - Can Fite Biopharma Ltd Sponsored ADR Stock Trading

Can-Fite Biopharma Ltd Sponsored ADR(NYSE: CANF) stock trading, description, contact, officers and directors.

About Can-Fite Biopharma Ltd Sponsored ADR

None

Stock Information

Can-Fite Biopharma Ltd Sponsored ADR Company Name:

CANF Stock Symbol:

NYSE Market:

Get CANF Alerts

News, Short Squeeze, Breakout and More Instantly...

CANF - Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies

Patent applications filed to protect discovery of cannabinoid-based therapies where the A3AR target is overexpressed including liver cancer Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small m...
CANF - Can-Fite: Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million

In addition, to date ~$20 million in non-dilutive upfront payment received Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, t...
CANF - Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update

$5M cash infusion received in warrant exercises and upfront money from a licensing deal “2020 was a pivotal year for Can-Fite as we demonstrated a robust clinical proof of concept for both Piclidenoson and Namodenoson,” stated Can-Fite CEO Dr. Pnina Fishman...